The combination of Keytruda and Padcev is taking another major step toward securing its position as a leading therapy in the ...

ImmunityBio says Anktiva plus BCG showed durable survival and bladder preservation at 36 months in BCG-unresponsive bladder ...

Recognizing common bladder cancer symptoms, such as blood in urine, can help you identify this disease in its early stages, when it may be more treatable.

Providing surgeons feedback and education on their performance significantly improved the quality of bladder cancer ...

Nanotube pathways enhance drug delivery in bladder cancer, improving hydroxycamptothecin penetration and efficacy in animal models. Barium titanate creates "nanotube highways," facilitating efficient ...

Armed with new three-year data demonstrating the benefits of Anktiva in a specific patient subset, ImmunityBio is proving its bladder cancer med is still one to watch as it competes with heavy hitt | ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

BKPyV infection is often asymptomatic or mild during childhood, but may leave a lasting impact on cancer risk. In A Nutshell ...

Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced that European Urology Oncology published results of a clinical study demonstrating ...

Tackling a common childhood virus could open the door to preventing bladder cancer, according to new research.